Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
academic, acetate, acknowledged, African, agonist, Alabama, amylinomimetic, analog, andBydureon, andByetta, andIxempra, andPlavix, assigned, began, borne, Bydureon, Byetta, competing, complement, concerningPlavix, conform, convertible, coordinated, Council, dacarbazine, death, deemed, denial, disruption, essentially, exenatide, FPG, harm, hypertriglyceridemia, inherited, injectable, intent, inThe, Iowa, labeling, Lancet, leptine, lipodystrophy, loan, Louisiana, lump, maximum, mealtime, metreleptin, notification, NVAF, ofByetta, ofForxiga, ofOrenciain, path, pattern, Portuguese, PPG, pramlintide, predetermined, predict, pretax, promissory, redeem, redemption, repaid, resubmission, rollover, senior, suffered, suspension, thatOnglyza, theAvalide, thereof, threshold, toByetta, toSymlin, transition, transitioned, unsecured, unvested, usingByetta, vast, voluntarily, withYervoy, World, wrongful
Filing tables
Filing exhibits
Related press release
BMY similar filings
Filing view
External links